Head-to-head · Cost-Efficiency Index
Blue Haven RX vs LeanDose
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Blue Haven RX
Shoppers who read the FAQ carefully before trusting the homepage price.
Visit Blue Haven RXLeanDose
Shoppers in one of its 17 served states who don't mind an undisclosed price increase after month one.
Visit LeanDoseThe verdict
Blue Haven RX and LeanDose tie on the Cost-Efficiency Index at 61/100, so neither wins outright on the numbers. For most shoppers we'd start with Blue Haven RX (ranked #225, a hair above #230) — Shoppers who read the FAQ carefully before trusting the homepage price. But LeanDose is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Blue Haven RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Blue Haven RX | LeanDose |
|---|---|---|
| Cost-Efficiency Index | 61/100 | 61/100 |
| Semaglutide / mo | $149/mo (all doses, compounded) | $159/mo (starting dose, compounded) |
| Tirzepatide / mo | $179/mo (all doses, compounded) | $279/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $1,908 |
| Tirzepatide / yr (modeled) | $2,148 | $3,348 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #225 | #230 |
Blue Haven RX
61/100Where the value is
- Claims flat, dose-independent pricing ('no price increases' regardless of dose)
- Routes to established physician networks (Wasef Health, Beluga Health) rather than an unknown in-house provider
- Payments held until doctor approval, per site copy, reducing risk of paying for a declined prescription
The tradeoffs
- Internal pricing contradiction: homepage says tirzepatide is $179/month, FAQ says $259/month
- No named medical director
LeanDose
61/100Where the value is
- Names its actual compounding pharmacy (Striker Pharmacy) unlike most competitors
- Real LegitScript certification badge with verifiable link
- Explicit published states-served list
The tradeoffs
- Headline prices are explicitly 'first month' only -- ongoing renewal price is never disclosed
- Only serves 17 states
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.